戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 oRNA biomarker/mechanism for toxic epidermal necrolysis.
2 tevens-Johnson syndrome, and toxic epidermal necrolysis.
3 tevens-Johnson syndrome, and toxic epidermal necrolysis.
4 Stevens-Johnson syndrome and toxic epidermal necrolysis.
5 Stevens-Johnson syndrome and toxic epidermal necrolysis.
6  Stevens-Johnson syndrome or toxic epidermal necrolysis.
7 es the epidermal necrosis in toxic epidermal necrolysis and provides a potential target for therapeut
8                              Toxic epidermal necrolysis and Stevens-Johnson syndrome are severe cutan
9 rge burst of nitric oxide in toxic epidermal necrolysis and Stevens-Johnson syndrome may cause the ep
10 progress to life-threatening toxic epidermal necrolysis, and colitis, characterized by a mild to mode
11  the pathogenesis of eczema, toxic epidermal necrolysis, and drug-induced skin eruptions.
12 ng from pneumococcal sepsis, toxic epidermal necrolysis, and renal failure) occurred at doses exceedi
13 Stevens-Johnson syndrome and toxic epidermal necrolysis are severe adverse cutaneous drug reactions c
14 and Stevens-Johnson syndrome/toxic epidermal necrolysis, can be severe and result in a diverse set of
15 for Stevens-Johnson syndrome/toxic epidermal necrolysis over a 14-year period were included.
16 our Stevens-Johnson syndrome/toxic epidermal necrolysis patients and is associated with a poor outcom
17  of Stevens-Johnson syndrome/toxic epidermal necrolysis patients at higher risk of intubation could h
18        A teenage survivor of toxic epidermal necrolysis presented with faint but diffuse dyschromia c
19 Stevens-Johnson syndrome and toxic epidermal necrolysis remain among the most devastating of acute co
20 e Algorithm for Drug Causality for Epidermal Necrolysis, respectively.
21 Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS/TEN) are rare but severe adverse reactio
22 Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS/TEN), although a detailed description is
23 s-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) among carbamazepine users, especially i
24                              Toxic epidermal necrolysis (TEN) and Stevens-Johnson Syndrome (SJS) are
25 s-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are life-threatening disorders.
26 s-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are rare but life-threatening condition
27 s-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are rare but life-threatening mucocutan
28 evens-Johnson syndrome (SJS)/toxic epidermal necrolysis (TEN) as a model to study the pathologic role
29                              Toxic epidermal necrolysis (TEN) is a severe adverse drug reaction invol
30 vens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and graft-versus-host disease (GVHD) a
31 vens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), drug rash with eosinophilia and system
32 vens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), or drug rash with eosinophilia and sys
33 s-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN).
34 e Algorithm for Drug Causality for Epidermal Necrolysis was highly probable or probable in all cases.
35  the placebo group had fatal toxic epidermal necrolysis with concurrent Pseudomonas aeruginosa bacter

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。